(Q44833599)

English

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium

scientific article published on 30 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pulmonary tuberculosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Charles M. Heilig

object named as

Charles M Heilig

8

0 references

object named as

Jason E Stout

3

0 references

Harriet Mayanja-Kizza

0 references

Eric Nuermberger

16

object named as

Eric L Nuermberger

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Susan E Dorman

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Stefan Goldberg

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Grace Muzanyi

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

John L Johnson

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Marc Weiner

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Lorna Bozeman

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pei-Jean Feng

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ruth Moro

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Masahiro Narita

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Payam Nahid

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Susan Ray

13

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Edward Bates

14

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Betial Haile

15

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Andrew Vernon

17

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Neil W Schluger

18

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Tuberculosis Trials Consortium

19

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

30 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

206

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1030-1040

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Potent twice-weekly rifapentine-containing regimens in murine tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Effect of meals on rifampicin absorption

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS461

21 January 2018

Identifiers

10.1093/INFDIS/JIS461

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44833599&oldid=2048847386"